Company Update

Venmax Drugs & Pharmaceuticals has filed a compliance certificate for the quarter ended June 30, 2025. This certificate, issued by its Registrar and Share Transfer Agent, confirms that the company has properly managed all share transfer and dematerialization requests from investors during the quarter.

This is a standard filing, assuring shareholders that their requests for converting physical shares to electronic format or vice-versa, and related share transfers, are processed efficiently and correctly.

It signifies the company's ongoing adherence to investor service standards.